Search hospitals > New York > New York

Memorial Sloan Kettering Cancer Center

Claim this profile
New York, New York 10065
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lymphoma
Conducts research for Tumors
Conducts research for Leukemia
4169 reported clinical trials
428 medical researchers
Photo of Memorial Sloan Kettering Cancer Center in New YorkPhoto of Memorial Sloan Kettering Cancer Center in New YorkPhoto of Memorial Sloan Kettering Cancer Center in New York

Summary

Memorial Sloan Kettering Cancer Center is a medical facility located in New York, New York. This center is recognized for care of Cancer, Breast Cancer, Lymphoma, Tumors, Leukemia and other specialties. Memorial Sloan Kettering Cancer Center is involved with conducting 4,169 clinical trials across 1,649 conditions. There are 428 research doctors associated with this hospital, such as Christopher J. Forlenza, Andrea Cercek, MD, Ira Dunkel, MD, and Thomas Kaley, MD.

Area of expertise

1Cancer
Global Leader
Memorial Sloan Kettering Cancer Center has run 610 trials for Cancer. Some of their research focus areas include:
Stage IV
Stage III
Stage II
2Breast Cancer
Global Leader
Memorial Sloan Kettering Cancer Center has run 460 trials for Breast Cancer. Some of their research focus areas include:
Stage IV
Stage III
HER2 negative

Top PIs

Clinical Trials running at Memorial Sloan Kettering Cancer Center

Gastroesophageal Junction Adenocarcinoma
Esophageal Adenocarcinoma
Esophageal Carcinoma
Breast Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Cancer
Brain Tumor
Anal Cancer
Ovarian Tumors
Image of trial facility.

Proton Therapy vs Photon Radiation

for Esophageal Cancer

This study is evaluating whether a type of radiation therapy may be more effective than another type of radiation therapy in treating esophageal cancer.
Recruiting2 awards Phase 31 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Memorial Sloan Kettering Cancer Center?
Memorial Sloan Kettering Cancer Center is a medical facility located in New York, New York. This center is recognized for care of Cancer, Breast Cancer, Lymphoma, Tumors, Leukemia and other specialties. Memorial Sloan Kettering Cancer Center is involved with conducting 4,169 clinical trials across 1,649 conditions. There are 428 research doctors associated with this hospital, such as Christopher J. Forlenza, Andrea Cercek, MD, Ira Dunkel, MD, and Thomas Kaley, MD.
Where is Memorial Sloan Kettering Cancer Center located?
Memorial Sloan Kettering Cancer Center is situated at 1275 York Avenue, New York, NY, nestled between 67th and 68th streets. For the main entrance, head south on York Avenue and make a right turn onto East 66th Street. The parking garage is conveniently located a quarter block from the corner, on the right side of 66th Street.
Who should I call to ask about financial aid or insurance network?
Memorial Sloan Kettering Cancer Center (MSK) offers comprehensive support for patients, including: - **Insurance Assistance**: For queries, contact 800-525-2225. - **Financial Assistance Program (FAP)**: Helps manage treatment costs based on income and assets. Apply by calling 646-227-3378. - **Prescription Assistance**: Aids patients with high medication co-pays. - **Social Worker Support**: Offers emotional support and practical assistance, including transportation and financial issues.
What insurance does Memorial Sloan Kettering Cancer Center accept?
Memorial Sloan Kettering Cancer Center (MSK) accepts various insurance plans, including Medicare and Medicaid. Patients are responsible for co-insurance, deductible costs for Medicare, and co-payments for Medicaid. MSK has relationships with many insurance providers, including Aetna, Blue Cross Blue Shield, Cigna, and UnitedHealthcare, among others. For specific plan participation and financial assistance options, please contact MSK directly. For insurance inquiries, call 646-497-9176; for billing questions, call 646-227-3378, Monday through Friday.
What awards or recognition has Memorial Sloan Kettering Cancer Center received?
Memorial Sloan Kettering Cancer Center (MSK) is renowned for its groundbreaking research and exceptional care, leading over 900 clinical trials aimed at enhancing treatment for adult and pediatric cancers. From 1980 to 2015, the US Food and Drug Administration approved ten drugs developed by MSK, showcasing an unmatched success rate among cancer centers. Additionally, MSK scientists have earned national and international accolades for their pioneering contributions to science and medicine.